Page 149 - Eceptor News Today

Researchers identified recurrent mutations in SARS-CoV-2.

Researchers presented a technique called rapid in vitro inhibition assay (RIVIA), whereby potential SARS-CoV-2 antibody and nanobody candidates can be rapidly screened.

Recent findings published in JAMA Oncology found that individual insurance status and residential zip codes were correlated with overall survival among women with early hormone receptor-positive breast cancer.

SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections.

Researchers directly compared the pre-fusion spikes of SARS-CoV-2 Alpha and Beta variants with the original Wuhan strain and the D614G-only variant.

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

A new study reports finds very low aldosterone levels in a subset of COVID-19 patients.

A new study discusses the outcomes of idiopathic pulmonary fibrosis patients with confirmed SARS-CoV-2 infection.

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

New research discussed the function and impact of humoral immune responses in COVID-19.